de Beaurepaire Renaud, Trinh Isabelle, Guirao Sophie, Taieb Muriel
GHPG, Villejuif, France.
BMJ Case Rep. 2015 Feb 26;2015:bcr2014207912. doi: 10.1136/bcr-2014-207912.
A 39-year-old man with bipolar disorder was hospitalised for depression. He was started on quetiapine (titrated up to 300 mg), lactulose (a laxative) and tropatepine (an anticholinergic). Valpromide (a mood stabiliser) and prazepam were later added and rapidly withdrawn. Seven days after quetiapine initiation, the patient reported abdominal pain and constipation; 2 days later, CT revealed an important distention of the colon including the caecum and a pre-perforation. A subtotal colectomy was performed and histology confirmed necrotising ischaemic colitis. The patient survived. This is the first case reported so far of ischaemic colitis related to quetiapine, in the absence of other antipsychotics simultaneously prescribed. Tropatepine likely acted as a cofactor to determine colitis. Clinicians need to be aware of the potential danger of the co-prescription of quetiapine with tropatepine (and possibly other anticholinergics).
一名患有双相情感障碍的39岁男性因抑郁症住院。他开始服用喹硫平(滴定至300毫克)、乳果糖(一种泻药)和托哌特罗(一种抗胆碱能药物)。后来添加了丙戊酰胺(一种情绪稳定剂)和普拉西泮,随后又迅速停用。服用喹硫平7天后,患者报告腹痛和便秘;2天后,CT显示结肠包括盲肠明显扩张且有穿孔前表现。进行了次全结肠切除术,组织学证实为坏死性缺血性结肠炎。患者存活。这是迄今为止报道的首例与喹硫平相关的缺血性结肠炎病例,且未同时开具其他抗精神病药物。托哌特罗可能作为一种辅助因素导致了结肠炎。临床医生需要意识到喹硫平与托哌特罗(可能还有其他抗胆碱能药物)联合处方的潜在危险。